We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUO
10376
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
$164K ﹤0.01%
+12,954
New +$159K
VRCA icon
10377
CALL
Verrica Pharmaceuticals
VRCA
$85.9M
$164K ﹤0.01%
5,970
+4,180
+234% +$112K
MLNK
10378
DELISTED
MeridianLink
MLNK
$164K ﹤0.01%
11,952
-25,293
-68% -$390K
SEEL
10379
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$164K ﹤0.01%
63
+1
+2% +$3.49K
SMIN icon
10380
iShares MSCI India Small-Cap ETF
SMIN
$771M
$164K ﹤0.01%
+3,165
New +$168K
KNBE
10381
CALL
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$164K ﹤0.01%
6,600
-107,900
-94% -$2.63M
LTRPA
10382
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$164K ﹤0.01%
244,218
+149,877
+159% +$141K
CLPT icon
10383
CALL
ClearPoint Neuro
CLPT
$466M
$163K ﹤0.01%
19,300
-39,000
-67% -$370K
YELL
10384
CALL
DELISTED
Yellow Corporation Common Stock
YELL
$163K ﹤0.01%
65,100
+8,800
+16% +$31.3K
DO
10385
DELISTED
Diamond Offshore Drilling, Inc.
DO
$163K ﹤0.01%
15,711
-32,157
-67% -$294K
CVSA
10386
CALL
Covista Inc
CVSA
$4.5B
$163K ﹤0.01%
4,600
-6,700
-59% -$262K
CYCN icon
10387
CALL
Cyclerion Therapeutics
CYCN
$17.7M
$163K ﹤0.01%
12,440
+305
+3% +$3.61K
HTLF
10388
CALL
DELISTED
Heartland Financial USA, Inc.
HTLF
$163K ﹤0.01%
+3,500
New +$165K
CERS icon
10389
PUT
Cerus
CERS
$613M
$163K ﹤0.01%
44,700
-85,300
-66% -$322K
WHF icon
10390
PUT
WhiteHorse Finance
WHF
$151M
$163K ﹤0.01%
+12,500
New +$158K
CONN
10391
PUT
DELISTED
Conn's Inc.
CONN
$163K ﹤0.01%
23,700
+1,100
+5% +$8.69K
STN icon
10392
CALL
Stantec
STN
$8.41B
$163K ﹤0.01%
+3,400
New +$164K
CONN
10393
DELISTED
Conn's Inc.
CONN
$163K ﹤0.01%
23,680
-2,556
-10% -$20.2K
ENTA icon
10394
PUT
Enanta Pharmaceuticals
ENTA
$380M
$163K ﹤0.01%
3,500
-12,900
-79% -$588K
CABA icon
10395
PUT
Cabaletta Bio
CABA
$466M
$163K ﹤0.01%
17,600
-300
-2% -$1.09K
HDB icon
10396
HDFC Bank
HDB
$119B
$163K ﹤0.01%
4,756
-234,798
-98% -$7.62M
SAFE
10397
CALL
Safehold
SAFE
$1.07B
$163K ﹤0.01%
3,408
-11,569
-77% -$557K
SRTY icon
10398
PUT
ProShares UltraPro Short Russell2000
SRTY
$66.2M
$162K ﹤0.01%
750
-6,875
-90% -$1.48M
KDNY
10399
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$162K ﹤0.01%
6,200
-254,000
-98% -$5.63M
BGSF icon
10400
CALL
BGSF Inc
BGSF
$60.4M
$162K ﹤0.01%
10,600
-3,200
-23% -$40.9K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.